Company Monitoring Page for Roche

latest headlines for company on cafepharma

All Eyes on Biogen as Roche Alzheimer’s Drug Flunks Final Test
Xconomy
Wed, 01/30/19 - 11:56 am
Tags:
Roche, Alzheimer's disease, clinical trials, AC Immune, crenezumab, Biogen, aducanumab
FDA Gives Greenlight to Janssen and AbbVie's Imbruvica for the 10th Time
BioSpace
Mon, 01/28/19 - 12:11 pm
Tags:
Imbruvica, Janssen, AbbVie, Roche, Gazyva, chronic lymphocytic leukemia, small lymphocytic lymphoma, FDA
Last week in biopharma - earnings reports, drug pricing, a new GENE CEO and more
CP Wire
Sun, 01/27/19 - 07:09 pm
Tags:
earnings, drug pricing, Genentech, Eli Lilly, Medtronic, Roche, M&A, Takeda, GSK, FDA
Sun, 01/27/19 - 07:07 pm
Tags:
earnings, drug pricing, Genentech, Eli Lilly, Medtronic, Roche, M&A, Takeda, GSK, FDA
Alexander Hardy tapped to head back to South San Francisco as the next CEO at Genentech
Endpoints
Thu, 01/24/19 - 11:50 am
Tags:
Genentech, Roche, Alexander Hardy, Pharma CEOs
Basilea Enters Collaboration With Roche to Study BAL087 in Combination With Tecentriq in Urothelial Cancer
CP WIre
Thu, 01/24/19 - 11:43 am
Tags:
Arqule, Basilea, Roche, BAL087, urothelial cancer, Tecentriq
Thu, 01/24/19 - 10:38 am
Tags:
Arqule, Basilea, Roche, BAL087, urothelial cancer, Tecentriq
Roche says 'no thanks' to megadeals, but don't count out smaller M&A
Fierce Pharma
Tue, 01/22/19 - 11:50 am
Tags:
Roche, M&A, Christoph Franz
FDA Approves 17th Biosimilar, Third for Herceptin
RAPS.org
Fri, 01/18/19 - 09:44 pm
Tags:
FDA, Merck, Samsung Bioepis, Ontruzant, biosimilars, Roche, Herceptin
Phoenix, Roche partner to develop TNBC biomarker
BioCentury
Wed, 01/16/19 - 11:57 pm
Tags:
Roche, Phoenix Molecular Designs, diagnostics, molecular diagnostics, triple negative breast cancer, biomarkers
NASH Space in Focus in 2019 as Firms Look to Diversify
Yahoo/Zacks.com
Sun, 01/13/19 - 11:32 am
Tags:
NASH, Gilead Sciences, Merck, Roche, Novartis, Jecure Therapeutics, Pfizer, Celgene, Eli Lilly
Genentech Cutting More Jobs in Bay Area
BioSpace
Wed, 01/2/19 - 11:23 am
Tags:
Genentech, Roche, layoffs, Bay Area
Down but Not Out: 10 Biggest Drug Trials That Saw Challenges in 2018
BioSpace
Fri, 12/21/18 - 12:10 pm
Tags:
clinical trials, Takeda, Zinfandel Pharmaceuticals, pioglitazone, Alzheimer's disease, Boehringer Ingelheim, BI 409306, Merck, verubecestat, Celgene, MS, ozanimod, Incyte, ID01, melanoma, vTv Therapeutics, azeliragon, Roche, Tecentriq, Exelixis, colorectal cancer, JNJ, atabacestat, Sareptat Therapeutics, DMD, Exondys 51, Alkermes, ALKS-5461, clinical depression
Merck taps Roche for Keytruda companion diagnostic
Medtech Dive
Wed, 12/12/18 - 06:41 pm
Tags:
Merck, Roche, solid tumors, oncology, biomarkers, companion diagnostics, diagnostics
Gilead Taps Roche Veteran Daniel O’Day as New CEO
BioSpace
Mon, 12/10/18 - 11:58 am
Tags:
Gilead Sciences, Pharma CEOs, Roche, Daniel O'Day
China approves Descovy, Harvoni, Hemlibra
BioCentury
Tue, 12/4/18 - 11:51 pm
Tags:
China, Harvoni, Descovy, Hemlibra, Roche, Gilead Sciences
One more shot at slowing Keytruda’s first-line lung cancer domination
EP Vantage
Wed, 11/28/18 - 10:12 am
Tags:
Keytruda, Merck, Roche, Tecentriq, Avastin, lung cancer
Roche Gains Place in NASH Race with Purchase of Jecure Therapeutics
Xconomy
Tue, 11/27/18 - 11:41 pm
Tags:
Roche, Jecure Therapeutics, M&A, NASH, Genentech
AbbVie, Roche aim to face down Pfizer with Venclexta’s move into AML arena
Fierce Pharma
Mon, 11/26/18 - 12:35 pm
Tags:
AbbVie, Venclexta, Roche, AML
FDA Approves Roche Subsidiary's Treatment for Acute Myeloid Leukemia
Yahoo/Guru Focus
Sat, 11/24/18 - 01:27 pm
Tags:
Roche, Genentech, Venclexta, FDA, AML, acute myeloid leukemia

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.